Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - AXIM BIOTECHNOLOGIES, INC. | form8k.htm |
Exhibit 16.1
SECURITIES AND EXCHANGE COMMISSION
Division of Corporation Finance
100 F Street, N.E., Mail Stop 7010
Washington, D.C. 20549
Re: AXIM International, Inc. (the “Company”)
Form 8-K, Item 4.01, dated May 14, 2014 (the “Report”)
Gentlemen:
We have reviewed the above referenced Report filed by the Company. We agree with the statements made by the Company in the Report and authorize the Company to file a copy of this letter as an exhibit to the Report.
Jeffrey & Company
/s/ Jeffrey & Company
Wayne, New Jersey
May 16, 2014